TOI The Oncology Institute, Inc.

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is reimagining oncology care by delivering highly specialized, value-based cancer care in the community setting. TOI is dedicated to offering cutting-edge, evidence-based cancer care to a population of more than 1.5 million patients including clinical trials, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced tertiary care institutions. With 80+ employed clinicians and more than 600 teammates in 50 clinic locations and growing, TOI is changing oncology care for the better.

$4.27  -0.01 (-0.23%)
As of 09/23/2022 15:59:54 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Care Facilities
Index country:  USA
Country of incorporation:  
IPO date:  11/15/2021
Outstanding shares:  73,495,500
Average volume:  315,629
Market cap:   $314,560,740
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BL6CB69
Valuation   (See tab for details)
PE ratio:   49.94
PB ratio:   2.38
PS ratio:   0.87
Return on equity:   9.09%
Net income %:   3.33%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy